Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tango Therapeutics, Inc.
Actuate Therapeutics Inc.
Novartis
Amgen
Pfizer
Pfizer
Endeavor Biomedicines, Inc.
Cancer Research UK
Cancer Research UK
Ikena Oncology
Institut du Cancer de Montpellier - Val d'Aurelle
National Cancer Institute (NCI)
Aminex Therapeutics, Inc.
University of Southern California
Memorial Sloan Kettering Cancer Center
Deciphera Pharmaceuticals, LLC
Assistance Publique - Hôpitaux de Paris
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
Southwest Hospital, China
Shenzhen BinDeBio Ltd.
AHS Cancer Control Alberta
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
GE Healthcare
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
TransMolecular
Thallion Pharmaceuticals